Register Login

Ionis Pharmaceuticals Inc (IONS)

Devers Shannon L. 🟡 adjusted position in 44.2K shares (5 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $85.36 ($8.3M) Transaction Date: Jan 07, 2026 | Filing ID: 000029

Full text
Register to leave comments
  • News bot Jan. 9, 2026, 10:10 p.m.

    🔍 Devers Shannon L. (Executive)

    Company: IONIS PHARMACEUTICALS INC (IONS)

    Report Date: 2026-01-07

    Transaction Summary:

    • Total transactions: 15
    • Derivative instruments: 5
    • Holdings reported: 0
    • Total shares acquired: 44,199
    • Total shares sold: 88,398

    Detailed Transactions and Holdings:

    • Acquired 25,545 shares of Common Stock at $56.78 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 43,039.00 | transaction_form_type: 4
    • Sold 25,545 shares of Common Stock at $85.36 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,494.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 2,101 shares of Common Stock at $32.6 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 19,595.00 | transaction_form_type: 4
    • Sold 2,101 shares of Common Stock at $85.36 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,494.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 3,460 shares of Common Stock at $32.6 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 20,954.00 | transaction_form_type: 4
    • Sold 3,460 shares of Common Stock at $84.62 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,494.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 3,829 shares of Common Stock at $37.58 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 21,323.00 | transaction_form_type: 4
    • Sold 3,829 shares of Common Stock at $84.62 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,494.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 9,264 shares of Common Stock at $52.87 per share (Direct)
      Date: 2026-01-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,758.00 | transaction_form_type: 4
    • Sold 9,264 shares of Common Stock at $84.62 per share (Direct)
      Date: 2026-01-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 17,494.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 2,101 shares of Non-Qualified Stock Option (right to buy) at $32.6 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2032-01-02 | Exercise: 2023-01-03 | equity_swap_involved: 0 | shares_owned_after: 11,339.00 | transaction_form_type: 4
    • Sold 3,460 shares of Non-Qualified Stock Option (right to buy) at $32.6 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2032-01-02 | Exercise: 2023-01-03 | equity_swap_involved: 0 | shares_owned_after: 7,879.00 | transaction_form_type: 4
    • Sold 3,829 shares of Non-Qualified Stock Option (right to buy) at $37.58 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2033-01-02 | Exercise: 2024-01-03 | equity_swap_involved: 0 | shares_owned_after: 9,254.00 | transaction_form_type: 4
    • Sold 9,264 shares of Non-Qualified Stock Option (right to buy) at $52.87 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2034-01-01 | Exercise: 2024-01-02 | equity_swap_involved: 0 | shares_owned_after: 9,262.00 | transaction_form_type: 4
    • Sold 25,545 shares of Non-Qualified Stock Option (right to buy) at $56.78 per share (Derivative)
      Date: 2026-01-07 | Code: M | Expires: 2028-01-03 | Exercise: 2022-01-04 | equity_swap_involved: 0 | shares_owned_after: 2,971.00 | transaction_form_type: 4

    Footnotes:

    • F1: Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024.
    • F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.10 to $85.64 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) on this Form 4.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.08 to $85.08 inclusive. The reporting person undertakes to provide to Ionis Pharmaceuticals, Inc. any security holder of Ionis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.

Search

News categories